One randomized clinical trial in patients with cirrhosis suggested benefit in achieving and maintaining abstinence with the use of baclofen, a -aminobutyric acid B receptor agonist

Chapters: 00:00 Intro & Jay Campbell Discussion 04:34 School Platform Update & Growth 10:04 Postpartum Peptides & Breastfeeding 15:49 Chelation Therapy & Heavy Metals 22:53 High Cholesterol & Statin Debate 28:20 Peptide Storage & Shelf Life 30:10 Retatrutide Weight Loss Concerns 34:25 CJC vs Tesamorelin Breakdown 37:08 Advanced Athlete Stack Optimization 43:04 Carnivore Diet & Injury Recovery 47:31 Female Fat Loss & Hormone Protocols 52:46 Osgood-Schlatter & BPC Discussion We cover: Peptides Post-C-Section & Breastfeeding: Safe options after delivery, what to avoid during breastfeeding, and topical alternatives for scarring and hair loss Chelation Therapy Support Stack: How EBOO compares, and why glutathione, SS-31, MOTS-C, Dihexa, and oral BPC are strong companions through heavy metal detox High Cholesterol Without Statins: Why most cholesterol numbers are overblown, the history behind the fat-vs-sugar debate, and smarter alternatives to statin drugs MOTS-C Shelf Life After Reconstitution: What we actually know about peptide degradation and the practical rule of thumb for staying in the potency window Coming Off Retatrutide Without Regaining Weight: Why slow tapering, high protein, and building muscle on-cycle are the keys to keeping your results CJC-1295 vs

Regulation of skin lightening agents in the United States and implications for public health
Interpretation of metabolic memory phenomenon using a physiological systems model: what drives oxidative stress following glucose normalization
E.HartS.LisBalchinM.et al (2001)